298 related articles for article (PubMed ID: 22445245)
1. Role of the renin-angiotensin system in the pathogenesis of intimal hyperplasia: therapeutic potential for prevention of vein graft failure?
Osgood MJ; Harrison DG; Sexton KW; Hocking KM; Voskresensky IV; Komalavilas P; Cheung-Flynn J; Guzman RJ; Brophy CM
Ann Vasc Surg; 2012 Nov; 26(8):1130-44. PubMed ID: 22445245
[TBL] [Abstract][Full Text] [Related]
2. Radial artery graft patency relates to gender, diabetes mellitus and angiotensin inhibition.
Bartnes K; Hermansen SE; Dahl-Eriksen O; Iqbal A; Mannsverk JT; Steigen TK; Trovik T; Busund R; Dahl PE; Sørlie DG; Myrmel T
Scand Cardiovasc J; 2010 Aug; 44(4):230-6. PubMed ID: 20331352
[TBL] [Abstract][Full Text] [Related]
3. Cell-permeant peptide inhibitors of vasospasm and intimal hyperplasia.
Osgood MJ; Flynn CR; Komalavilas P; Brophy C
Vascular; 2013 Feb; 21(1):46-53. PubMed ID: 23104826
[TBL] [Abstract][Full Text] [Related]
4. Role of smooth muscle cells in coronary artery bypass grafting failure.
Wadey K; Lopes J; Bendeck M; George S
Cardiovasc Res; 2018 Mar; 114(4):601-610. PubMed ID: 29373656
[TBL] [Abstract][Full Text] [Related]
5. Introduction of embryonic stem cells into vein grafts reduces intimal hyperplasia in mice.
Breuer S; Fogelstrand P; Lindskog H; Osterberg K; Luebke T; Brunkwall J; Mattsson E
J Cardiovasc Surg (Torino); 2014 Apr; 55(2):235-46. PubMed ID: 23369946
[TBL] [Abstract][Full Text] [Related]
6. Gene delivery to aortocoronary saphenous vein grafts in a large animal model of intimal hyperplasia.
Petrofski JA; Hata JA; Gehrig TR; Hanish SI; Williams ML; Thompson RB; Parsa CJ; Koch WJ; Milano CA
J Thorac Cardiovasc Surg; 2004 Jan; 127(1):27-33. PubMed ID: 14752409
[TBL] [Abstract][Full Text] [Related]
7. Inhibitory Effect of TLR4 Gene Silencing on Intimal Hyperplasia of Vein Grafting.
Zhu Z; Xu R; Zheng X; Wang T; Li D; Wang Y; Liu K
Vasc Endovascular Surg; 2016 Oct; 50(7):464-469. PubMed ID: 27681173
[TBL] [Abstract][Full Text] [Related]
8. Role of Girdin in intimal hyperplasia in vein grafts and efficacy of atelocollagen-mediated application of small interfering RNA for vein graft failure.
Miyachi H; Mii S; Enomoto A; Murakumo Y; Kato T; Asai N; Komori K; Takahashi M
J Vasc Surg; 2014 Aug; 60(2):479-489.e5. PubMed ID: 23948670
[TBL] [Abstract][Full Text] [Related]
9. Saphenous vein graft disease, pathophysiology, prevention, and treatment. A review of the literature.
Guida G; Ward AO; Bruno VD; George SJ; Caputo M; Angelini GD; Zakkar M
J Card Surg; 2020 Jun; 35(6):1314-1321. PubMed ID: 32353909
[TBL] [Abstract][Full Text] [Related]
10. External support in preventing vein graft failure.
Hu J; Wan S
Asian Cardiovasc Thorac Ann; 2012 Oct; 20(5):615-22. PubMed ID: 23087319
[TBL] [Abstract][Full Text] [Related]
11. Modulation of phosphatidylinositol 3-kinase signaling reduces intimal hyperplasia in aortocoronary saphenous vein grafts.
Hata JA; Petrofski JA; Schroder JN; Williams ML; Timberlake SH; Pippen A; Corwin MT; Solan AK; Jakoi A; Gehrig TR; Kontos CD; Milano CA
J Thorac Cardiovasc Surg; 2005 Jun; 129(6):1405-13. PubMed ID: 15942585
[TBL] [Abstract][Full Text] [Related]
12. Early growth response gene-1 decoy oligonucleotides inhibit vascular smooth muscle cell proliferation and neointimal hyperplasia of autogenous vein graft in rabbits.
Wang X; Mei Y; Ji Q; Feng J; Cai J; Xie S
Interact Cardiovasc Thorac Surg; 2015 Jul; 21(1):50-4. PubMed ID: 25820759
[TBL] [Abstract][Full Text] [Related]
13. Endothelin-1, endothelin receptor antagonists, and vein graft occlusion in coronary artery bypass surgery: 20 years on and still no journey from bench to bedside.
Dashwood MR; Loesch A
Can J Physiol Pharmacol; 2020 Sep; 98(9):570-578. PubMed ID: 32343914
[TBL] [Abstract][Full Text] [Related]
14. Coronary artery bypass graft: why is the saphenous vein prone to intimal hyperplasia?
Sur S; Sugimoto JT; Agrawal DK
Can J Physiol Pharmacol; 2014 Jul; 92(7):531-45. PubMed ID: 24933515
[TBL] [Abstract][Full Text] [Related]
15. External Stents for Vein Grafts in Coronary Artery Bypass Grafting: Targeting Intimal Hyperplasia.
Weltert LP; Wolf LG; Garufi L; Scaffa R; Salica A; Ricci A; Irace FG; Fusca S; D'Aleo S; Chirichilli I; Bellisario A; de Paulis R
Surg Technol Int; 2020 May; 35():197-201. PubMed ID: 32120449
[TBL] [Abstract][Full Text] [Related]
16. Histological and morphometric analyses of early and late aortocoronary vein grafts and distal anastomoses.
Butany JW; David TE; Ojha M
Can J Cardiol; 1998 May; 14(5):671-7. PubMed ID: 9627522
[TBL] [Abstract][Full Text] [Related]
17. Long-term performance of an external stent for saphenous vein grafts: the VEST IV trial.
Taggart DP; Webb CM; Desouza A; Yadav R; Channon KM; De Robertis F; Di Mario C
J Cardiothorac Surg; 2018 Nov; 13(1):117. PubMed ID: 30453984
[TBL] [Abstract][Full Text] [Related]
18. Use of Brilliant Blue FCF during vein graft preparation inhibits intimal hyperplasia.
Osgood MJ; Sexton K; Voskresensky I; Hocking K; Song J; Komalavilas P; Brophy C; Cheung-Flynn J
J Vasc Surg; 2016 Aug; 64(2):471-478. PubMed ID: 27763268
[TBL] [Abstract][Full Text] [Related]
19. Statin therapy and saphenous vein graft disease after coronary bypass surgery: analysis from the CASCADE randomized trial.
Kulik A; Voisine P; Mathieu P; Masters RG; Mesana TG; Le May MR; Ruel M
Ann Thorac Surg; 2011 Oct; 92(4):1284-90; discussion 1290-1. PubMed ID: 21958773
[TBL] [Abstract][Full Text] [Related]
20. Differential action of angiotensin II and activity of angiotensin-converting enzyme in human bypass grafts.
Borland JA; Chester AH; Crabbe S; Parkerson JB; Catravas JD; Yacoub MH
J Thorac Cardiovasc Surg; 1998 Aug; 116(2):206-12. PubMed ID: 9699571
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
